pdr001 Search Results


pdr001  (Novartis)
90
Novartis pdr001
Pdr001, supplied by Novartis, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pdr001/product/Novartis
Average 90 stars, based on 1 article reviews
pdr001 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
pdr001  (Palobiofarma)
90
Palobiofarma pdr001
Clinical trials with adenosine pathway inhibitors combined with an immune check inhibitor in cancer
Pdr001, supplied by Palobiofarma, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pdr001/product/Palobiofarma
Average 90 stars, based on 1 article reviews
pdr001 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
pdr001 + lcl161 (oral small molecule smac-mimetic)  (SMAC Corp)
90
SMAC Corp pdr001 + lcl161 (oral small molecule smac-mimetic)
Current clinical trials of PD-1 and PD-L1 inhibitors in multiple myeloma
Pdr001 + Lcl161 (Oral Small Molecule Smac Mimetic), supplied by SMAC Corp, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pdr001 + lcl161 (oral small molecule smac-mimetic)/product/SMAC Corp
Average 90 stars, based on 1 article reviews
pdr001 + lcl161 (oral small molecule smac-mimetic) - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
anti-pd1 (pdr001  (AstraZeneca ltd)
90
AstraZeneca ltd anti-pd1 (pdr001
Current clinical trials of PD-1 and PD-L1 inhibitors in multiple myeloma
Anti Pd1 (Pdr001, supplied by AstraZeneca ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti-pd1 (pdr001/product/AstraZeneca ltd
Average 90 stars, based on 1 article reviews
anti-pd1 (pdr001 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


Clinical trials with adenosine pathway inhibitors combined with an immune check inhibitor in cancer

Journal: Immune Network

Article Title: Adenosine Blockage in Tumor Microenvironment and Improvement of Cancer Immunotherapy

doi: 10.4110/in.2019.19.e23

Figure Lengend Snippet: Clinical trials with adenosine pathway inhibitors combined with an immune check inhibitor in cancer

Article Snippet: A2AR , PFB509 , Novartis/Palobiofarma , I, Ib , NSCLC , PDR001 (anti-PD-1) , NCT02403193.

Techniques: Clinical Proteomics

Current clinical trials of PD-1 and PD-L1 inhibitors in multiple myeloma

Journal: Journal of Hematology & Oncology

Article Title: Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1/PD-L1 pathway

doi: 10.1186/s13045-018-0589-1

Figure Lengend Snippet: Current clinical trials of PD-1 and PD-L1 inhibitors in multiple myeloma

Article Snippet: CJM112 (anti-IL-17A) alone or with PDR001 PDR001 + LCL161 (oral small molecule SMAC-mimetic) , RRMM , Phase 1 , Recruiting (NCT03111992).

Techniques: Clinical Proteomics